NEW YORK – Bionano Genomics reported after the close of the market on Thursday a 31 percent year-over-year decrease in its fourth quarter revenues.
The San Diego-based genome mapping firm reported $2.8 million in Q4 revenue, down from $4.0 million a year ago. Revenues consisted of $1.5 million in instrument revenue, down 50 percent from Q4 2018 and consumables revenue of $1.1 million, up 35 percent from the prior year period.